Involvement of adaptor proteins in clathrin-mediated endocytosis of virus entry
The first step in the initiation of effective viral infection is breaking through the cytomembrane to enter the cell. Clathrin-mediated endocytosis is a key vesicular trafficking process in which a variety of cargo molecules are transported from the outside to the inside of the cell. This process is...
Gespeichert in:
Veröffentlicht in: | Microbial pathogenesis 2021-12, Vol.161 (Pt A), p.105278-105278, Article 105278 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The first step in the initiation of effective viral infection is breaking through the cytomembrane to enter the cell. Clathrin-mediated endocytosis is a key vesicular trafficking process in which a variety of cargo molecules are transported from the outside to the inside of the cell. This process is hijacked by numerous families of enveloped or non-enveloped viruses, which use it to enter host cells, followed by trafficking to their replicating sites. Various adaptor proteins that assist in cargo selection, coat assembly, and clathrin-coated bud maturation are important in this process. Research data documented on the involvement of adaptor proteins, such as AP-2, Eps-15, Epsin1, and AP180/CALM, in the invasion of viruses via the clathrin-mediated endocytosis have provided novel insights into understanding the viral life cycle and have led to the development of novel therapeutics. Here, we summarize the latest discoveries on the role of these adaptor proteins in clathrin-mediated endocytosis of virus entry and also discuss the future trends in this field.
•Clathrin-mediated endocytosis (CME) is a major entry pathway for many viruses.•Various adaptor proteins, including AP-2, Eps-15, Epsin1, and AP180/CALM, involve in the CME of virus entry.•The adaptor proteins participated in the CME of virus entry may be antiviral targets for therapeutic intervention. |
---|---|
ISSN: | 0882-4010 1096-1208 |
DOI: | 10.1016/j.micpath.2021.105278 |